A. M. SEDEF Et Al. , "Non-Small-Cell Lung Cancer (NSCLC) harboring driver mutation (EGFR mutation or ALK Translocations) with clinical characteristics and management in a real-life setting: a retrospective observational multicenter case series study," International Congress on Oncological Sciences 2017 , Antalya, Turkey, 2017
SEDEF, A. M. Et Al. 2017. Non-Small-Cell Lung Cancer (NSCLC) harboring driver mutation (EGFR mutation or ALK Translocations) with clinical characteristics and management in a real-life setting: a retrospective observational multicenter case series study. International Congress on Oncological Sciences 2017 , (Antalya, Turkey).
SEDEF, A. M., ÇALIKUŞU, Z., BAKKAL TEMİ, Y., Gökçay, S., MERTSOYLU, H., BEŞEN, A. A., ... KÖSE, F.(2017). Non-Small-Cell Lung Cancer (NSCLC) harboring driver mutation (EGFR mutation or ALK Translocations) with clinical characteristics and management in a real-life setting: a retrospective observational multicenter case series study . International Congress on Oncological Sciences 2017, Antalya, Turkey
SEDEF, ALİ Et Al. "Non-Small-Cell Lung Cancer (NSCLC) harboring driver mutation (EGFR mutation or ALK Translocations) with clinical characteristics and management in a real-life setting: a retrospective observational multicenter case series study," International Congress on Oncological Sciences 2017, Antalya, Turkey, 2017
SEDEF, ALİ M. Et Al. "Non-Small-Cell Lung Cancer (NSCLC) harboring driver mutation (EGFR mutation or ALK Translocations) with clinical characteristics and management in a real-life setting: a retrospective observational multicenter case series study." International Congress on Oncological Sciences 2017 , Antalya, Turkey, 2017
SEDEF, A. M. Et Al. (2017) . "Non-Small-Cell Lung Cancer (NSCLC) harboring driver mutation (EGFR mutation or ALK Translocations) with clinical characteristics and management in a real-life setting: a retrospective observational multicenter case series study." International Congress on Oncological Sciences 2017 , Antalya, Turkey.
@conferencepaper{conferencepaper, author={ALİ MURAT SEDEF Et Al. }, title={Non-Small-Cell Lung Cancer (NSCLC) harboring driver mutation (EGFR mutation or ALK Translocations) with clinical characteristics and management in a real-life setting: a retrospective observational multicenter case series study}, congress name={International Congress on Oncological Sciences 2017}, city={Antalya}, country={Turkey}, year={2017}}